2026年9月11日 下午6:07 UTC / 路透社
作者：戴安娜·诺瓦克·琼斯
2026年9月11日 下午6:07 UTC 更新于24分钟前
[1/2]2025年4月14日，法国欧莱雅集团的标志出现在其位于巴黎近郊克利希的总部大楼上。路透社/斯特凡妮·勒科克
9月11日（路透社）——亚利桑那州已起诉欧莱雅集团及其美国子公司，指控这家化妆品公司隐瞒其直发产品可能导致女性患癌的证据，而该公司目前正面临数千名消费者及其家属提起的同类诉讼。
亚利桑那州总检察长、民主党人克里斯汀·梅斯于周四晚间在州法院提起诉讼，使亚利桑那州成为首个就直发产品涉嫌致癌风险提起诉讼的州。诉讼指控欧莱雅违反州消费者保护法，在未告知消费者据称存在的卵巢癌和子宫癌风险的情况下，推广其主要面向非裔女性的直发产品。
订阅《每日案卷》新闻简报，将最新法律资讯直接发送至您的收件箱，开启您的清晨资讯之旅。点击此处注册。
广告 · 继续向下滚动
该州正在寻求罚款和赔偿，同时要求法院下令禁止欧莱雅继续销售这些产品，除非其标注致癌风险警告。
亚利桑那州的诉讼称，在数十年面向女性和儿童的产品营销中，欧莱雅及其关联公司“利用了几个世纪以来针对非裔群体的社会压力和歧视性美容标准，同时将利润置于消费者安全之上”。
此次诉讼提起之际，该公司正面临超过1.2万起由女性或其家属提起的同类诉讼。这些诉讼已被合并至芝加哥联邦法院，作为多地区诉讼程序的一部分，该程序旨在更高效地处理在多个司法辖区提起的诉讼。
广告 · 继续向下滚动
欧莱雅美国公司的一名发言人表示，公司对其产品的安全性充满信心，并认为这些诉讼在法律和科学层面均站不住脚。
2022年研究
这些产品以“Dark and Lovely”、“Optimum”等品牌销售，宣称可以永久拉直卷发。
2022年美国国立卫生研究院发布一项研究后，首批相关诉讼被提交至法院。该研究发现，每年多次使用这类产品的女性患子宫癌的风险是其他女性的两倍以上。
欧莱雅的发言人周五表示，该研究并未认定使用这类产品与原告所称的任何病症之间存在因果关系。
这些诉讼要求赔偿女性遭受的痛苦和折磨，以及医疗账单和产品费用等经济损失。
https://www.reuters.com/legal/litigation/arizona-accuses-loreal-concealing-cancer-risks-linked-hair-relaxers-2026-09-11/
这些诉讼不仅起诉了欧莱雅，还包括露华浓等其他直发产品制造商。露华浓也否认其产品与癌症存在关联。
法院记录显示，该多地区诉讼程序仍在推进中，庭审可能于明年启动。
广告 · 继续向下滚动
戴安娜·诺瓦克·琼斯报道，亚历克西亚·加拉姆法尔维与奥罗拉·埃利斯编辑
我们的准则：路透社诚信准则
Arizona accuses L’Oreal of concealing cancer risks linked to hair relaxers
2026-09-11 6:07 PM UTC / Reuters
By Diana Novak Jones
September 11, 2026 6:07 PM UTC Updated 24 mins ago
[1/2]The logo of French cosmetics Groupe L’Oreal is seen on the L’Oreal group’s headquarters building in Clichy, near Paris, France, April 14, 2025. REUTERS/Stephanie Lecocq
Sept 11 (Reuters) – Arizona has sued L’Oreal SA and its U.S. subsidiary, alleging the cosmetics company hid evidence that its hair relaxer products could cause cancer in women, as it faces thousands of similar lawsuits from users and their families.
Arizona Attorney General Kristin Mayes, a Democrat, filed the lawsuit late Thursday in state court, making Arizona the first state to sue over alleged cancer risks linked to hair relaxers. The lawsuit accuses L’Oreal of violating state consumer protection laws by marketing the products, which are used predominantly by African American women, without warning consumers about the alleged risks of ovarian and uterine cancers.
Jumpstart your morning with the latest legal news delivered straight to your inbox from The Daily Docket newsletter. Sign up here.
Advertisement · Scroll to continue
The state is seeking penalties and damages, as well as a court order forcing L’Oreal to stop selling the products unless it warns of the cancer risk.
In marketing the products to women and children over decades, L’Oreal and associated companies “exploited centuries of social pressures and discriminatory beauty standards affecting people of African descent, all while prioritizing profit over consumer safety,” Arizona’s lawsuit claims.
The lawsuit comes as the company faces more than 12,000 similar lawsuits filed by women or their families that have been consolidated in a Chicago federal court as part of a multidistrict litigation proceeding, a procedure designed to more efficiently manage lawsuits filed in multiple jurisdictions.
Advertisement · Scroll to continue
A spokesperson for L’Oreal USA said the company is confident in the safety of its products and believes the claims are without legal or scientific merit.
A 2022 STUDY
The products, which have been marketed under the names Dark and Lovely, Optimum and other brands, promise to permanently straighten textured hair.
The first lawsuits hit the docket after the 2022 release of a study done by the National Institutes of Health that found women who used the products several times a year were more than twice as likely to develop uterine cancer.
L’Oreal’s spokesperson said Friday the study made no finding of a causal connection between the use of those products and any conditions alleged by the plaintiffs.
The lawsuits seek damages to compensate the women for their pain and suffering and economic damages for medical bills and the cost of the products, among other things.
https://www.reuters.com/legal/litigation/arizona-accuses-loreal-concealing-cancer-risks-linked-hair-relaxers-2026-09-11/
The lawsuits name L’Oreal, as well as Revlon and other makers of the products. Revlon has also denied a connection between cancer and the products.
The multidistrict litigation continues to move forward, court records show, and trials could begin next year.
Advertisement · Scroll to continue
Reporting by Diana Novak Jones, Editing by Alexia Garamfalvi and Aurora Ellis
Our Standards: The Thomson Reuters Trust Principles.
发表回复